These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 18180005

  • 41. A timely reminder about an evolving clinical entity: nephrogenic systemic fibrosis and gadolinium use in CKD.
    Jamboti J.
    Nephrology (Carlton); 2007 Jun; 12(3):316. PubMed ID: 17498132
    [No Abstract] [Full Text] [Related]

  • 42. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 43. Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.
    Todd DJ, Kay J.
    Curr Rheumatol Rep; 2008 Jul 01; 10(3):195-204. PubMed ID: 18638427
    [Abstract] [Full Text] [Related]

  • 44. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Cowper SE, Kuo PH, Bucala R.
    Arthritis Rheum; 2007 Oct 01; 56(10):3173-5. PubMed ID: 17907160
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Extracellular gadolinium-based contrast media: an overview.
    Bellin MF, Van Der Molen AJ.
    Eur J Radiol; 2008 May 01; 66(2):160-7. PubMed ID: 18358659
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS, Zic JA, Abraham JL.
    J Am Acad Dermatol; 2007 Jan 01; 56(1):27-30. PubMed ID: 17109993
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Nephrogenic systemic fibrosis: epidemiology update.
    Marckmann P.
    Curr Opin Nephrol Hypertens; 2008 May 01; 17(3):315-9. PubMed ID: 18408485
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May 01; 66(2):180-3. PubMed ID: 18342468
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Periocular papules in nephrogenic systemic fibrosis.
    Introcaso CE, Elenitsas R, Xu X, James WD.
    J Am Acad Dermatol; 2008 Sep 01; 59(3):536-7. PubMed ID: 18625538
    [No Abstract] [Full Text] [Related]

  • 57. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization.
    Swaminathan S, Horn TD, Pellowski D, Abul-Ezz S, Bornhorst JA, Viswamitra S, Shah SV.
    N Engl J Med; 2007 Aug 16; 357(7):720-2. PubMed ID: 17699829
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.